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Abstract 
Background: Although nocturia has been reported to increase mortality in elderly individuals, the particular risk fac-
tors that are associated with this event are unclear. Therefore, we evaluated risk factors for death in outpatients with 
nocturia.
Methods: Between October 2002 and December 2009, 250 consecutive patients with nocturia were enrolled in 
two general hospitals in Japan. Among them, 193 patients were able to be followed for at least 1 year and up to 
9 years (median 4.8 years) if the patients did not die. Mortality rates and risk factors were evaluated in the nocturic 
outpatients.
Results: Two- and 5-year survival of the nocturic outpatients was 94.6 % [95 % confidence interval (CI) = 92.2–97.1] 
and 82.6 % (95 % CI = 75.4–87.8), respectively. Higher Charlson Comorbidity Score, lower body mass index (BMI) 
and lower Physical Component Summary of Short Form-36 item scores were significantly correlated with mortal-
ity (p < 0.0001, p < 0.005 and p < 0.05, respectively) in multivariate analysis. The International Prostate Symptom 
Score, Pittsburgh Sleep Quality Index, Mental or Role/Social Component Summary of Short Form-36 item scores and 
Nocturnal Polyuria index were not significantly correlated with mortality. The mortality rate was significantly higher in 
subjects with an underweight BMI (<18.50) compared with a normal range (18.50–24.99) or overweight (≥25.00) BMI 
[p < 0.00005, hazard ratio (HR) = 5.84, 95 % CI = 2.03–16.8; p < 0.0005, HR = 5.92, 95 % CI = 1.94–18.0].
Conclusions: Additional attention is required for nocturic outpatients with not only a high Charlson Comorbidity 
Score but also an underweight BMI because of their high mortality. Large prospective studies are warranted to vali-
date this finding and extend more.
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Background
Nocturia is a common lower urinary tract symptom 
(LUTS), which is associated with impaired quality of life 
(QOL), particularly when two or more episodes occur 
per night [1, 2]. Several epidemiological studies have 
reported increased mortality in people with nocturia [3–
6]. According to the Third National Health and Nutrition 
Examination Survey, which included more than 15,000 
people, there is a significant trend of increased mortality 
risk with increased number of nightly voiding episodes in 
men and women [5]. Bursztyn et al. suggested that noc-
turia was a significant independent predictor of mortality 
among 70-year-old patients with coronary heart diseases 
[4]. These studies have provided important information 
regarding the effect of nocturia on mortality. However, 
the risk factors of morality in nocturic patients remain 
unclear, and a direct relationship between nocturia and 
mortality has not been clearly shown yet [7].
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Because the cause of nocturia is multifactorial, includ-
ing prostatic hyperplasia, age, psychological aspects, 
and medical problems, such as hypertension, diabetes, 
stroke, and obesity, the cause-and-effect associations are 
not always obvious [7]. These multifactorial and unclear 
aspects can also be applied to the cause of death in noc-
turic patients. However, nocturic patients might have 
a common risk factor in death. Therefore, we retro-
spectively reviewed the survival rate of outpatients who 
attended large general hospitals with the chief complaint 
of nocturia, and evaluated risk factors for death using 
multivariate statistics.
Methods
A total of 250 patients who attended the urology section 
of two general hospitals (Kurashiki Central Hospital and 
Kyoto University Hospital) with the chief complaint of 
nocturia (two or more episodes) between October 2002 
and December 2009 were enrolled in this study with 
written informed consent. We reviewed the patients’ 
records to determine their survival and causes of death. 
When insufficient data were achieved from the records, 
we used postal mail and telephone calls. The study con-
formed to the provisions of the Declaration of Helsinki 
and was approved by Kyoto University Graduate School 
and the Faculty of Medicine Ethics Committee (E-1037).
The follow-up period was at least 1  year and up to 
9  years (median 5  years) if the patients did not die. We 
also evaluated age at the first visit, sex, body mass index 
(BMI), Charlson Comorbidity Score [8], and scores on 
several questionnaires administered at the first visit, to 
analyze correlates of mortality (Additional file  1). The 
number of nocturnal voids was evaluated using the sev-
enth question of the International Prostate Symptom 
Score (IPSS). The questionnaires used in this study were 
the IPSS for assessment of general LUTS [9], the Medical 
Outcome Study Short Form-36 item (SF-36) for health-
related QOL (HRQOL) [10, 11] and the Pittsburgh Sleep 
Quality Index for sleep status [12]. The Japanese versions 
of these questionnaires have been previously validated 
[13–15] The Nocturnal Polyuria index (NPi), determined 
as nocturnal urine volume divided by total urine volume 
[1], was calculated from the bladder diary for at least 
2 days. Prospectively collected data from these question-
naires were analyzed retrospectively in this study. Survival 
curves were obtained by the Kaplan–Meier method. We 
used Cox’s proportional hazards model to assess risk fac-
tors for death. The assumption of proportional hazards 
was checked by testing for time-dependent hazards. Risk 
factors included age at first visit, sex (categorized), BMI, 
IPSS score 7, IPSS total score, IPSS QOL, SF-36 PCS, 
SF-36 MCS, SF-36 RCS, PSQI, NPi and Charlson Comor-
bidity Score. We performed forward stepwise regression 
analysis to determine the association between several fac-
tors and a death in nocturic patients. Interaction between 
BMI and other factors were also examined. The SPSS 
ver.11.0.1J software (SPSS Inc., Chicago, IL, USA) was 
used statistical analyses. Survival curves were obtained 
by the Kaplan–Meier method with BMI categorized into 
three groups according to the WHO criteria (underweight 
<18.50; normal range 18.50–24.99; overweight ≥25.0).
Results
We were able to follow 193 (77.2  %) patients up to 
110  months (median 58.2  months) and 40 (20.1  %) 
patients died. The baseline characteristics of the study 
population are shown in Table 1 and in Additional file 1. 
Two- and 5-year survival of the nocturic outpatients 
was 94.6  % (95  % CI  =  92.2–97.1) and 82.6  % (95  % 
CI  =  75.4–87.8), respectively. Kaplan–Meier estimates 
of all-cause mortality in outpatients with nocturia are 
shown in Additional file  1. The causes of death of the 
nocturic patients were malignancy (n = 16, 40.0 %), res-
piratory infection (n  =  5, 12.5  %), hematologic disease 
(n = 3, 7.5 %), cardiovascular disease (n = 2, 5.0 %), dia-
betes mellitus (n = 2, 5.0 %) and others (n = 12, 30.0 %; 
including traffic accidents, rheumatism, pneumothorax, 
spinocerebellar degeneration, suicide, senility, spinal 
infraction, and unknown).
Univariate analysis showed that age at the first visit 
(p  ≤  0.001), low BMI (p  ≤  0.0001), low SF-36 Physi-
cal Component Summary score (p  ≤  0.01) and Charl-
son Comorbidity Score (p  ≤  0.0001) were significant 
Table 1 Clinical characteristics of the study population
IQR interquartile range, BMI body mass index, IPSS International Prostate 
Symptom Score, SF-36 Medical Outcome Study Short Form-36 item for health-
related QOL, PCS Physical Component Summary, MCS Mental Component 
Summary, RCS Role Component Summary, PSQI Pittsburgh Sleep Quality Index, 
NPi Nocturnal Polyuria index
Characteristics Total
No. patients 193
Age, median (IQR) (years) 73 (11)
Female, no. (%) 37 (19.2)
BMI, median (IQR) 22.5 (3.4)
IPSS score 7, median (IQR) 4 (1)
IPSS total score, median (IQR) 15 (9)
IPSS QOL, median (IQR) 4 (1)
SF-36 PCS, median (IQR) 46.0 (14.6)
SF-36 MCS, median (IQR) 49.8 (12.9)
SF-36 RCS, median (IQR) 47.0 (23.0)
PSQI, median (IQR) 8 (6.8)
NPi, median (IQR) 0.43 (0.32)
Charlson Comorbidity Score 1 (2)
Follow up (years) 4.85 (4.99)
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correlates of mortality, while frequency of nocturia 
shown by IPSS score 7 or relative nighttime urine pro-
duction indicated by NPi was not (Table 2). In multivari-
ate analysis, low BMI, low SF-36 Physical Component 
Summary score and high Charlson Comorbidity Score 
were significantly correlated with mortality [p  <  0.005, 
hazard ratio (HR)  =  0.83, 95  % confidence interval 
(CI) = 0.74–0.94; p < 0.05, HR = 0.97, 95 % CI = 0.95–
1.00; p < 0.0001, HR = 1.44, 95 % CI = 1.21–1.71, respec-
tively; no significant interaction was observed between 
BMI and Charlson Comorbidity Score or SF-36 PCS] 
(Table 2).
Patients were divided into three groups according 
to BMI of WHO criteria (underweight <18.50, normal 
range 18.50–24.99, overweight ≥25.0) (Table 3). Kaplan–
Meier curves of the three BMI groups are shown in 
Fig. 1. The mortality rate was significantly higher in sub-
jects with underweight BMI compared with those with 
normal range or overweight (p  <  0.00005, HR  =  5.84, 
95  % CI  =  2.03–16.8; p  <  0.0005, HR  =  5.92, 95  % 
CI = 1.94–18.0).
Discussion
In this study, we showed that underweight BMI, as well 
as lower Physical Component Summary of Short Form-
36 item scores and high Charlson Comorbidity Score, 
was a risk factor of mortality of nocturic outpatients in 
two general hospitals in Japan (Kurashiki Central Hospi-
tal and Kyoto University Hospital).
Of note, high BMI is suggested as a risk factor for noc-
turia [16]. Therefore, a higher BMI population tends to 
be more nocturic than others, similar to metabolic syn-
drome. However, whether BMI is related to mortality 
of nocturic patients is unknown. BMI did not have any 
significant interaction with Charlson Comorbidity Score 
or Physical Component Summary of Short Form-36 
item, indicating that participants did not tend have low 
Table 2 Cox regression analyses predicting the death 
in nocturia patients
Univariate analysis
OR (95 % CI) P value*
Age at first visit 1.09 (1.04–1.14) <0.001
Female 0.53 (0.21–1.35) 0.18
BMI 0.81 (0.73–0.90) <0.0001
IPSS score 7 1.17 (0.83–1.64) 0.38
IPSS total score 1.01 (0.96–1.01) 0.78
IPSS QOL 1.17 (0.88–1.56) 0.29
SF-36 PCS 0.97 (0.94–0.99) <0.01
SF-36 MCS 0.99 (0.96–1.03) 0.54
SF-36 RCS 0.99 (0.96–1.01) 0.3
PSQI 1.00 (0.91–1.09) 0.93
NPi 0.59 (0.06–5.60) 0.64
Charlson Comorbidity Score 1.42 (1.24–1.63) <0.0001
Multivariate analysis
OR (95 % CI) P value*
Age at first visit 1.05 (0.98–1.11) 0.15
BMI 0.83 (0.74–0.94) <0.005
SF-36 PCS 0.97 (0.95–1.00) <0.05
Charlson Comorbidity Score 1.44 (1.21–1.71) <0.0001
Table 3 Clinical characteristics of  the patients according 
to the BMI
Characteristics BMI P value*
<18.50 18.50–24.99 ≥25.00
No. patients 22 128 43
Age (years), median 
(IQR)
75 (10) 73 (11) 70 (9) <0.05
Female, no. (%) 7 (31.8) 23 (18.0) 7 (16.3) 0.27
BMI, median (IQR) 17.4 (1.5) 21.9 (3.1) 27.1 (3.4) NA
IPSS score 7, median 
(IQR)
4 (1.3) 4 (1.0) 4 (1) 0.54
IPSS total score, 
median (IQR)
11 (13.8) 15 (9) 15 (10) 0.74
IPSS QOL, median 
(IQR)
5 (1) 5 (1) 4 (1.3) 0.21
SF-36 PCS, median 
(IQR)
40.3 (25.6) 46.1 (14.4) 47.0 (11.6) 0.74
SF-36 MCS, median 
(IQR)
48.0 (13.4) 50.2 (14.1) 49.5 (12.5) 0.46
SF-36 RCS, median 
(IQR)
38.9 (30.5) 47.1 (23.3) 47.1 (23.3) 0.3
PSQI, median (IQR) 9 (6) 8 (7) 7.5 (7) 0.81
NPi, median (IQR) 0.46 (0.37) 0.43 (0.32) 0.43 (0.35) 0.59
Charlson Comorbidity 
Score
1 (2) 1 (2) 0 (2) 0.36
Follow up (years), 
median (IQR)
4.27 (3.25) 4.73 (4.91) 5.65 (6.07) 0.21
Fig. 1 Kaplan–Meier survival curves of the three BMI groups. Under 
<18.5, normal 18.5–24.99, over ≥25.0
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BMI simply because they were ill. It has recently been 
reported that BMI is inversely related to all-cause mor-
tality in elderly people [17, 18]. A large study conducted 
in Japan showed that a low BMI in elderly people was 
associated with an increased risk of all-cause mortality, 
and the results were essentially unchanged, even when 
the analyses were conducted in those who did not have 
cancer, cardiovascular disease, or stroke [17]. Moreo-
ver, higher BMI patients had improved survival rate 
in decompensated congestive heart failure [19] and in 
chronic heart failure [20]. This paradoxical phenomenon 
was extended to the general population in a systemic 
review and meta-analysis [21]. The exact reasons are not 
clear, but explanations for this paradox are that lean mass 
acts as a nutritional preserve and thin older patients may 
have less immune response [22]. These factors may apply 
to nocturic elderly people.
In the present study, the cause of death largely 
depended on the comorbidities. This is considered to 
be because subjects were outpatients with nocturia 
from two relatively large general hospitals, although 
the survival rate of the nocturic patients in the present 
study was not lower than that of the Japanese popula-
tion calculated using age- and sex-specific population 
estimates released by the Japanese Ministry of Inter-
nal Affairs and Communications (using http://www.e-
stat.go.jp/SG1/estat/XlsdlE.do?sinfid=000000090264; 
data not shown). Therefore, we re-analyzed particu-
lar groups selected with Charlson Comorbidity Score 
between 0 and 2 (n = 166) in the same manner (Addi-
tional file 1). The result showed a clearer impact of BMI 
solely on the mortality, with hazard ratio of 0.73 (95 % 
CI 0.62-0.88) in multivariate analysis. The Charlson 
Comorbidity Score was not significantly related to the 
mortality in this particular group, indicating that multi-
ple comorbidities rather than the individual factor could 
drive the event. In addition, the overweight BMI group 
had a significantly better survival rate than the normal 
BMI group, with hazard ratio of 3.00 (p  <  0.05, 95  % 
CI = 1.01–8.94). This result suggests that although obe-
sity is reported to be a risk factor of nocturia, the over-
weight BMI is a favorable factor of survival in nocturic 
outpatients without comorbidity or with relatively mild 
one. This paradox can be compatible to the reported 
relationship between mortality and BMI after fracture 
[23].
There are several study limitations in this study. The 
purpose of this study was to assess the association of 
BMI and all-cause mortality, while further detailed 
study into the influence of BMI on the cause-specific 
mortality would be variable. The association between 
nocturia and falls/fractures, and its relation to mortal-
ity was reported [6, 24–26]. However, the low incidence 
of death in the present was not enough to evaluate it 
and we cannot find any case that had a direct relation 
to fractures and death in the present study except the 
case of traffic accident. The low incidence of death 
might not have sufficient power to evaluate the factor of 
death in nocturic patients, which indicate that the other 
covariates examined might have a relation to death. Age 
or sex-related disease could be associated with weight 
loss and death [17, 27]. In addition, it cannot be denied 
that other undetected factors are related to the mortal-
ity risk increased in low-BMI nocturic patients. Only 
one series of measures was obtained from participants, 
even though the survival rates was referred with that 
of the Japanese population calculated using age- and 
sex-specific population estimates released by the Japa-
nese Ministry of Internal Affairs and Communications. 
This design makes it difficult to ascribe directional-
ity to any other observed effects. Other limitations of 
this study are that participants were all Japanese, so 
the relationship of the BMI and mortality might be dif-
ferent in other countries. The lowest risk of mortality 
was observed in the middle and elderly Japanese peo-
ple with BMI between 21 and 27 [27]. Although the 
WHO expert consultation agreed the WHO BMI cut-
off points retained as international classifications, but 
the Asians generally have a higher percentage of body 
fat than Caucasians of the same age, sex, and BMI [28]. 
Further study is warranted in more ethnically diverse 
populations. Taking into account these limitations, we 
believe that our results give novel insights into risk fac-
tors of mortality in nocturic patients.
Conclusion
Additional attention should be paid to nocturic patients 
with underweight BMI visiting large general hospitals 
because they may have high mortality. Large prospective 
studies are needed to validate our findings and extend 
more.
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